ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer
European Journal of Cancer
◽
10.1016/s0959-8049(02)80299-4
◽
2002
◽
Vol 38
(11)
◽
pp. S95
Author(s):
J Baselga
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Preliminary Data
◽
Phase Ii Study
◽
Metastatic Breast
◽
Weekly Schedule
◽
Her2 Positive
Download Full-text
Related Documents
Cited By
References
SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer
Annals of Oncology
◽
10.1093/annonc/mdx365.084
◽
2017
◽
Vol 28
◽
pp. v106-v107
◽
Cited By ~ 3
Author(s):
P. Villagrasa Gonzalez
◽
A. Prat
◽
M. Oliveira
◽
L. de la Pena
◽
X. Gonzalez
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
232 Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC)
European Journal of Cancer
◽
10.1016/s0959-8049(12)70300-3
◽
2012
◽
Vol 48
◽
pp. S110
Author(s):
L. Petruzelka
◽
V. Ganju
◽
P.F. Conte
◽
N. Tubiana-Mathieu
◽
F. Majois
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study
Breast Cancer Research and Treatment
◽
10.1007/s10549-017-4203-y
◽
2017
◽
Vol 163
(3)
◽
pp. 507-515
◽
Cited By ~ 3
Author(s):
Konstantinos Tryfonidis
◽
◽
S. Marreaud
◽
H. Khaled
◽
B. De Valk
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Extracellular Domain
◽
Cardiac Safety
◽
Her2 Positive
◽
Serial Serum
Download Full-text
Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
Annals of Oncology
◽
10.1093/annonc/mdx365.015
◽
2017
◽
Vol 28
◽
pp. v81
Author(s):
N.M. Iyengar
◽
L.M. Smyth
◽
D. Lake
◽
A. Gucalp
◽
J.C. Singh
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
Abstract OT1-1-13: A phase II study with lead-in safety cohort of cabazitaxel plus lapatinib as therapy for patients with HER2-positive metastatic breast cancer (MBC) and intracranial metastases
10.1158/0008-5472.sabcs13-ot1-1-13
◽
2013
◽
Author(s):
DA Yardley
◽
JD Hainsworth
◽
E Hamilton
◽
LL Hart
◽
M Shastry
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
◽
Intracranial Metastases
Download Full-text
Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
Annals of Oncology
◽
10.1093/annonc/mdw365.49
◽
2016
◽
Vol 27
◽
pp. vi84
◽
Cited By ~ 1
Author(s):
N.M. Iyengar
◽
L. Smyth
◽
D. Lake
◽
A. Gucalp
◽
J. Singh
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with Her2-positive metastatic breast cancer - E-Vita -
Annals of Oncology
◽
10.1093/annonc/mdw365.52
◽
2016
◽
Vol 27
◽
pp. vi85
Author(s):
J. Bischoff
◽
J. Barinoff
◽
C. Mundhenke
◽
D. Bauerschlag
◽
S.D. Costa
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
◽
Randomized Phase Ii
Download Full-text
A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(04)90846-4
◽
2004
◽
Vol 2
(3)
◽
pp. 127
◽
Cited By ~ 1
Author(s):
M Untch
◽
S Kahlert
◽
L Petruzelka
◽
M Martin
◽
V Guillem-Porta
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
First Line
◽
Her2 Positive
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II study of the combination of oral vinorelbine (NVBo), capecitabine (X), and trastuzumab (H) in HER2-positive, metastatic breast cancer (MBC): Recent analysis of the results with a median follow-up of 44 months.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.1077
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 1077-1077
◽
Cited By ~ 4
Author(s):
L. B. Petruzelka
◽
V. Ganju
◽
D. Becquart
◽
P. F. Conte
◽
N. Tubiana-Mathieu
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Recent Analysis
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-Positive metastatic breast cancer (MBC) after prior HP- or TDM/P-based therapy.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.611
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. 611-611
Author(s):
Neil M. Iyengar
◽
Lillian Mary Smyth
◽
Maxine S. Jochelson
◽
Diana Lake
◽
Ayca Gucalp
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close